Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Amphastar Pharmaceuticals ( (AMPH) ) has shared an update.
On August 8, 2025, Amphastar Pharmaceuticals entered into a strategic licensing agreement with Nanjing Anji Biotechnology Co., Ltd. to develop and commercialize three proprietary peptides in the United States and Canada. This collaboration aims to enhance Amphastar’s pipeline in oncology and ophthalmology, with potential milestone payments to Anji reaching up to $453 million over the agreement’s term. The partnership underscores Amphastar’s commitment to advancing peptide therapeutics and expanding its market presence in high-growth areas.
The most recent analyst rating on (AMPH) stock is a Hold with a $31.00 price target. To see the full list of analyst forecasts on Amphastar Pharmaceuticals stock, see the AMPH Stock Forecast page.
Spark’s Take on AMPH Stock
According to Spark, TipRanks’ AI Analyst, AMPH is a Outperform.
Amphastar Pharmaceuticals’ overall stock score reflects strong financial performance and a solid valuation, indicating potential for growth. However, technical indicators suggest bearish sentiment, and mixed results from the earnings call highlight challenges in revenue and competition. The company’s strategic initiatives and product pipeline provide a positive outlook, balancing the current market pressures.
To see Spark’s full report on AMPH stock, click here.
More about Amphastar Pharmaceuticals
Amphastar Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing, manufacturing, and marketing complex generic and proprietary injectable, inhalation, and intranasal products. The company is strategically oriented towards the development of proprietary medicines, with its manufacturing operations based in the United States, China, and France. Amphastar’s products are primarily used in hospital or urgent care settings and retail pharmacies.
Average Trading Volume: 517,233
Technical Sentiment Signal: Sell
Current Market Cap: $1.27B
Find detailed analytics on AMPH stock on TipRanks’ Stock Analysis page.